Reactivation of ERK and Akt confers resistance of mutant BRAF colon cancer cells to the HSP90 inhibitor AUY922

Oncogenic mutations of BRAF occur in approximately 10% of colon cancers and are associated with their resistance to clinically available therapeutic drugs and poor prognosis of the patients. Here we report that colon cancer cells with mutant BRAF are also resistant to the heat shock protein 90 (HSP9...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chun Yan, Guo, Su Tang, Wang, Jia Yu, Yan, Xu Guang, Farrelly, Margaret, Zhang, Yuan Yuan, Liu, Fen, Yari, Hamed, La, Ting, Lei, Fu Xi, Jin, Lei, Zhang, Xu Dong, Jiang, Chen Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226532/
https://www.ncbi.nlm.nih.gov/pubmed/27391062
http://dx.doi.org/10.18632/oncotarget.10414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226532/
https://www.ncbi.nlm.nih.gov/pubmed/27391062
http://dx.doi.org/10.18632/oncotarget.10414

Ejemplares similares